Go Pro

KORU Medical Systems (KRMD) Competitors

KORU Medical Systems logo
$4.20 -0.17 (-3.89%)
Closing price 06/30/2026 04:00 PM Eastern
Extended Trading
$4.11 -0.09 (-2.14%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KRMD vs. SIBN, CBLL, SSII, SGP, and BBNX

Should you buy KORU Medical Systems stock or one of its competitors? MarketBeat compares KORU Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KORU Medical Systems include SiBone (SIBN), CeriBell (CBLL), SS Innovations International (SSII), Spyglass Pharma (SGP), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

How does KORU Medical Systems compare to SiBone?

KORU Medical Systems (NASDAQ:KRMD) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 3.9% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

KORU Medical Systems currently has a consensus price target of $7.25, suggesting a potential upside of 72.62%. SiBone has a consensus price target of $23.00, suggesting a potential upside of 40.93%. Given KORU Medical Systems' higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than SiBone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
SiBone
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, SiBone has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

KORU Medical Systems has a net margin of -5.27% compared to SiBone's net margin of -8.10%. SiBone's return on equity of -9.56% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
SiBone -8.10%-9.56%-7.06%

In the previous week, KORU Medical Systems had 2 more articles in the media than SiBone. MarketBeat recorded 3 mentions for KORU Medical Systems and 1 mentions for SiBone. SiBone's average media sentiment score of 1.87 beat KORU Medical Systems' score of 0.62 indicating that SiBone is being referred to more favorably in the news media.

Company Overall Sentiment
KORU Medical Systems Positive
SiBone Very Positive

KORU Medical Systems has higher earnings, but lower revenue than SiBone. KORU Medical Systems is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.69-$2.64M-$0.05N/A
SiBone$200.93M3.60-$18.90M-$0.39N/A

Summary

SiBone beats KORU Medical Systems on 9 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to CeriBell?

KORU Medical Systems (NASDAQ:KRMD) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 20.1% of CeriBell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

KORU Medical Systems has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market. Comparatively, CeriBell has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

KORU Medical Systems has higher earnings, but lower revenue than CeriBell. KORU Medical Systems is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M4.69-$2.64M-$0.05N/A
CeriBell$89.06M8.29-$53.41M-$1.63N/A

KORU Medical Systems has a net margin of -5.27% compared to CeriBell's net margin of -63.51%. KORU Medical Systems' return on equity of -13.61% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-5.27% -13.61% -8.33%
CeriBell -63.51%-38.19%-30.92%

In the previous week, CeriBell had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 5 mentions for CeriBell and 3 mentions for KORU Medical Systems. CeriBell's average media sentiment score of 0.96 beat KORU Medical Systems' score of 0.62 indicating that CeriBell is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CeriBell
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

KORU Medical Systems presently has a consensus target price of $7.25, suggesting a potential upside of 72.62%. CeriBell has a consensus target price of $22.20, suggesting a potential upside of 14.14%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than CeriBell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
CeriBell
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

CeriBell beats KORU Medical Systems on 9 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

SS Innovations International has a beta of -1.88, meaning that its stock price is 288% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

KORU Medical Systems has lower revenue, but higher earnings than SS Innovations International. KORU Medical Systems is trading at a lower price-to-earnings ratio than SS Innovations International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M19.55-$12.13M-$0.05N/A
KORU Medical Systems$41.13M4.69-$2.64M-$0.05N/A

SS Innovations International currently has a consensus price target of $7.00, suggesting a potential upside of 68.67%. KORU Medical Systems has a consensus price target of $7.25, suggesting a potential upside of 72.62%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than SS Innovations International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

KORU Medical Systems has a net margin of -5.27% compared to SS Innovations International's net margin of -20.69%. KORU Medical Systems' return on equity of -13.61% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-20.69% -23.00% -13.18%
KORU Medical Systems -5.27%-13.61%-8.33%

In the previous week, SS Innovations International had 5 more articles in the media than KORU Medical Systems. MarketBeat recorded 8 mentions for SS Innovations International and 3 mentions for KORU Medical Systems. SS Innovations International's average media sentiment score of 0.95 beat KORU Medical Systems' score of 0.62 indicating that SS Innovations International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

58.6% of KORU Medical Systems shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

KORU Medical Systems beats SS Innovations International on 10 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to Spyglass Pharma?

Spyglass Pharma (NASDAQ:SGP) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Spyglass Pharma currently has a consensus price target of $45.00, indicating a potential upside of 102.16%. KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 72.62%. Given Spyglass Pharma's stronger consensus rating and higher probable upside, analysts plainly believe Spyglass Pharma is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spyglass Pharma
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Spyglass Pharma has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Spyglass Pharma's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Spyglass PharmaN/A N/A N/A
KORU Medical Systems -5.27%-13.61%-8.33%

In the previous week, KORU Medical Systems had 2 more articles in the media than Spyglass Pharma. MarketBeat recorded 3 mentions for KORU Medical Systems and 1 mentions for Spyglass Pharma. Spyglass Pharma's average media sentiment score of 1.89 beat KORU Medical Systems' score of 0.62 indicating that Spyglass Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Spyglass Pharma Very Positive
KORU Medical Systems Positive

Spyglass Pharma has higher earnings, but lower revenue than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spyglass Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spyglass PharmaN/AN/AN/A-$6.41N/A
KORU Medical Systems$41.13M4.69-$2.64M-$0.05N/A

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Spyglass Pharma beats KORU Medical Systems on 8 of the 13 factors compared between the two stocks.

How does KORU Medical Systems compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

58.6% of KORU Medical Systems shares are owned by institutional investors. 5.3% of Beta Bionics shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

KORU Medical Systems has lower revenue, but higher earnings than Beta Bionics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beta Bionics$100.25M6.97-$73.20M-$1.51N/A
KORU Medical Systems$41.13M4.69-$2.64M-$0.05N/A

Beta Bionics has a beta of 3.4, suggesting that its stock price is 240% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

KORU Medical Systems has a net margin of -5.27% compared to Beta Bionics' net margin of -60.27%. KORU Medical Systems' return on equity of -13.61% beat Beta Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
Beta Bionics-60.27% -23.00% -20.55%
KORU Medical Systems -5.27%-13.61%-8.33%

In the previous week, Beta Bionics had 8 more articles in the media than KORU Medical Systems. MarketBeat recorded 11 mentions for Beta Bionics and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.62 beat Beta Bionics' score of -0.04 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beta Bionics
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Beta Bionics presently has a consensus target price of $19.70, indicating a potential upside of 25.72%. KORU Medical Systems has a consensus target price of $7.25, indicating a potential upside of 72.62%. Given KORU Medical Systems' higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Beta Bionics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beta Bionics
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.64
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

KORU Medical Systems beats Beta Bionics on 9 of the 17 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRMD vs. The Competition

MetricKORU Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$200.73M$1.73B$7.07B$12.45B
Dividend YieldN/AN/A2.66%6.16%
P/E Ratio-84.0080.0327.2424.87
Price / Sales4.697.84544.42102.84
Price / CashN/A24.8348.5358.59
Price / Book11.355.5910.956.54
Net Income-$2.64M-$54.76M$3.57B$336.70M
7 Day Performance0.24%3.60%2.28%2.81%
1 Month Performance3.19%-3.02%1.36%0.58%
1 Year Performance14.13%3.82%36.72%31.29%

KORU Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRMD
KORU Medical Systems
3.6628 of 5 stars
$4.20
-3.9%
$7.25
+72.6%
+17.3%$200.73M$41.13MN/A80
SIBN
SiBone
2.4224 of 5 stars
$15.95
+0.8%
$23.00
+44.2%
-13.3%$701.61M$200.93MN/A350
CBLL
CeriBell
1.9938 of 5 stars
$18.39
+1.2%
$22.20
+20.7%
+3.8%$689.80M$89.06MN/AN/A
SSII
SS Innovations International
2.2188 of 5 stars
$3.40
+1.2%
$7.00
+105.9%
-29.5%$672.44M$48.47MN/A4
SGP
Spyglass Pharma
2.7258 of 5 stars
$19.67
+1.7%
$45.00
+128.8%
N/A$657.63MN/AN/A65

Related Companies and Tools


This page (NASDAQ:KRMD) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners